Streetbeat News

Analyst Ratings

ASAN

Asana (NYSE:ASAN) has received a mix of analyst ratings in the last quarter, with an average 12-month price target of $22.4, which has increased by 8.37% over the past month.

Portfolio Pulse from Benzinga Insights

June 02, 2023 | 4:01 pm

PBF

In the last quarter, PBF Energy (NYSE:PBF) received 7 somewhat bullish ratings and 3 indifferent ratings from analysts. The average 12-month price target for PBF Energy is $51.0, representing an 8.52% decrease from the previous average of $55.75.

Portfolio Pulse from Benzinga Insights

June 02, 2023 | 4:00 pm

DELL

Evercore ISI Group analyst Amit Daryanani has reiterated an Outperform rating on Dell Technologies (NYSE:DELL) and maintained a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 4:00 pm

SHCR

BTIG analyst David Larsen reiterated a Buy rating on Sharecare (NASDAQ:SHCR) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:57 pm

ATVI

Truist Securities analyst Matthew Thornton has reiterated a Buy rating on Activision Blizzard (NASDAQ:ATVI) and maintained an $84 price target.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:55 pm

DOOO

TD Securities analyst Brian Morrison downgraded BRP (NASDAQ:DOOO) from Buy to Hold and lowered the price target from $135 to $110.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:52 pm

LUNMF

TD Securities analyst Greg Barnes upgrades Lundin Mining (OTC:LUNMF) from Hold to Buy and raises the price target from $11 to $11.5.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:48 pm

VZ

A whale investor has taken a bullish stance on Verizon Communications (NYSE:VZ), with 58% of detected trades showing bullish expectations. Whales have been targeting a price range of $30.0 to $39.0 for Verizon over the last 3 months. The stock is currently down 4.91% at $33.97, and RSI indicators suggest it may be oversold. Tigress Financial downgraded its action to Buy with a price target of $64.

Portfolio Pulse from Benzinga Insights

June 02, 2023 | 3:46 pm

AKBA

HC Wainwright & Co. analyst Ed Arce reiterated a Neutral rating on Akebia Therapeutics (NASDAQ:AKBA) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:43 pm

HLTH

Goldman Sachs downgraded Cue Health's stock from Buy to Neutral and lowered its price target from $2.75 to $0.75, causing the shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 02, 2023 | 3:30 pm